Study Stopped
Class I Recall (Feb 2026): Boston Scientific issued a global recall for specific lots of AXIOS 6x8mm and 8x8mm due to reports of deployment and expansion failure during the procedure.
EUS-Gallbladder vs CDS as First Line in MBDO- Palliative (CARPEGIEM Trial)
CARPEGIEM
Multicenter Study of EUS-guided Gallbladder Drainage vs Choledochoduodenostomy as First Line in Malignant Distal Obstruction in Palliative Patients (CARPEGIEM Trial): an Open-label, Randomized Controlled Clinical Trial
1 other identifier
interventional
128
1 country
10
Brief Summary
The aim of the study is to evaluate technical, clinical and safety outcomes of lumen-apposing metal stent (LAMS) with a coaxial double-pigtail plastic stent (DPS) in EUS-guided choledochoduodenostomies vs cholcystogastrostomy for the management of malignant biliary obstruction in palliative patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2024
Typical duration for not_applicable
10 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 16, 2024
CompletedFirst Posted
Study publicly available on registry
April 19, 2024
CompletedStudy Start
First participant enrolled
October 18, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 1, 2027
May 6, 2026
May 1, 2026
2 years
April 16, 2024
May 2, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
RELATED ADVERSE EVENTS
Safety will be measured by careful and comparative evaluation of adverse effects in both groups.
12 months
Patients with Recurrent biliary obstruction
Recurrent biliary obstruction (RBO) has been defined as a composite endpoint of either occlusion or migration.
12 months
Secondary Outcomes (6)
CLINICAL SUCCESS
2 weeks
TECHNICAL SUCCESS
24 hours
BILIARY REINTERVENTIONS (BRI)
12 months
HOSPITAL STAY
12 months
MORTALITY
12 months
- +1 more secondary outcomes
Study Arms (2)
EUS-GBD with LAMS-Pigtail
EXPERIMENTALBiliary drainage using EUS-guided Cholecystostomy with lumen apposing metal stent Echoendoscopy-guided Cholecystostomy (EUS-GBD) with deployment of a lumen-apposing metal stent (LAMS) and axis-orienting double-pigtail plastic stent throug LAMS. EUS-GBD technique: Diagnostic EUS. Classic or free-hand with preloaded guidewire cholecystostomy with LAMS. Pneumatic dilation whithin LAMS is allowed. 'push' technique'. Deployment of a pigtail coaxial to LAMS.
EUS-CDS with LAMS-Pigtail
ACTIVE COMPARATOREchoendoscopy-guided Choledochoduodenostomy (EUS-CDS) with deployment of a lumen-apposing metal stent (LAMS) and axis-orienting double-pigtail plastic stent throug LAMS. EUS-CDS technique: Diagnostic EUS. Classic or free-hand with preloaded guidewire choledochoduodenostomy with LAMS. Pneumatic dilation whithin LAMS is allowed. In case of bile duct \< 15mm is mandatory the 'push' technique. Deployment of a pigtail coaxial to LAMS.
Interventions
Decompression of the bile duct by endoscopic aproach.
Lumen-apposing metal stent (LAMS) with coaxial double-pigtail plastic stent (DPPS) deployment: * LAMS size: 6x8mm, 8x8mm. Consider 10x10mm or 10x15mm if abundant pathological material in gallblader. * DPPS size: 7Fr x 3-5-7cm.
Eligibility Criteria
You may qualify if:
- Malignant distal biliary obstruction diagnosed in patient considered PALIATIVE with biliary drainage indication.
- Consensual malignancy by a bilio-pancreatic multidisciplinar committe (histological confirmation is not mandatory)
- Patient capable of understanding and/or singning the informed consent.
- Patient who understands the type of study and will comply with all follow-up tests throughout its duration
You may not qualify if:
- Pregnancy or lactation.
- Severe coagulation disorder: INR \> 1.5 non correctable with plasma administration and/or platelet count \< 50.000/mm3.
- Previous cholecistectomy or gallblader perforation.
- Tumoral obstruction of cystic duct.
- Multiple liver metastases affecting more than 30% of the liver parenchyma
- Distal malignant biliary strictures in patients considered resectable or borderline.
- Benign or uncertain etiology of biliary strictures or strictures located proximally or in close proximity to the hilum.
- Patients with prior biliary stents or other biliary drainages (e.g., PTCD).
- Altered intestinal anatomy due to prior surgery that prevents or hinders papillary access \_\_\_\_\_\_\_\_\_\_\_\_\_\_ (e.g., gastric bypass, Billroth II, duodenal switch, Roux-en-Y).
- Gastric outlet obstruction.
- Situations that do not allow for upper gastrointestinal endoscopy (e.g., esophageal stricture).
- Patients with functional diversity, who lack the capacity to understand the nature and potential consequences of the study, except when a legal representative is available.
- Patients incapable of maintaining follow-up appointments (lack of adherence).
- Lack of informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hospital Universitari de Bellvitgelead
- Hospital Clínico Universitario de Valenciacollaborator
- Hospital General Universitario de Alicantecollaborator
- Hospital Mutua de Terrassacollaborator
- Hospital Universitario Ramon y Cajalcollaborator
- Hospital General Universitario de Castellóncollaborator
- Complejo Hospitalario de Navarracollaborator
- University Hospital Virgen de las Nievescollaborator
- Hospital de Sant Paucollaborator
- University of Salamancacollaborator
- Complejo Hospitalario Universitario de Santiagocollaborator
- Complejo Hospitalario Universitario de Vigocollaborator
Study Sites (10)
Hospital Universitari de Bellvitge
L'Hospitalet de Llobregat, BARCELONA, 08907, Spain
Hospital General Alicante
Alicante, Valencia, Spain
Hospital Universitari de Castello
Castellon, Valencia, Spain
Hospital Santa Creu I Sant Pau
Barcelona, Spain
Hospital Virgen de Las Nieves
Granada, Spain
Complejo Hospitalario de Pamplona
Pamplona, Spain
Hospital Santiago de Compostela
Santiago de Compostela, Spain
Hospital Mutua de Terrassa
Terrassa, Spain
Hospital Clinic de Valencia
Valencia, Spain
Hospital Cunqueiro de Vigo
Vigo, Spain
Related Publications (6)
Mangiavillano B, Moon JH, Facciorusso A, Vargas-Madrigal J, Di Matteo F, Rizzatti G, De Luca L, Forti E, Mutignani M, Al-Lehibi A, Paduano D, Bulajic M, Decembrino F, Auriemma F, Franchellucci G, De Marco A, Gentile C, Shin IS, Rea R, Massidda M, Calabrese F, Mirante VG, Ofosu A, Crino SF, Hassan C, Repici A, Larghi A. Endoscopic ultrasound-guided gallbladder drainage as a first approach for jaundice palliation in unresectable malignant distal biliary obstruction: Prospective study. Dig Endosc. 2024 Mar;36(3):351-358. doi: 10.1111/den.14606. Epub 2023 Jul 3.
PMID: 37253185BACKGROUNDBinda C, Anderloni A, Fugazza A, Amato A, de Nucci G, Redaelli A, Di Mitri R, Cugia L, Pollino V, Macchiarelli R, Mangiavillano B, Forti E, Brancaccio ML, Badas R, Maida M, Sinagra E, Repici A, Fabbri C, Tarantino I. EUS-guided gallbladder drainage using a lumen-apposing metal stent as rescue treatment for malignant distal biliary obstruction: a large multicenter experience. Gastrointest Endosc. 2023 Nov;98(5):765-773. doi: 10.1016/j.gie.2023.06.054. Epub 2023 Jun 29.
PMID: 37392954BACKGROUNDKamal F, Khan MA, Lee-Smith W, Sharma S, Acharya A, Farooq U, Aziz M, Kouanda A, Dai SC, Munroe CA, Arain M, Adler DG. Efficacy and safety of EUS-guided gallbladder drainage for rescue treatment of malignant biliary obstruction: A systematic review and meta-analysis. Endosc Ultrasound. 2023 Jan-Feb;12(1):8-15. doi: 10.4103/EUS-D-21-00206.
PMID: 36861505BACKGROUNDChen YI, Callichurn K, Chatterjee A, Desilets E, Fergal D, Forbes N, Gan I, Kenshil S, Khashab MA, Kunda R, Lam E, May G, Mohamed R, Mosko J, Paquin SC, Sahai A, Sandha G, Teshima C, Barkun A, Barkun J, Bessissow A, Candido K, Martel M, Miller C, Waschke K, Zogopoulos G, Wong C; ELEMENT trial and for the Canadian Endoscopic Research Collaborative (CERC). ELEMENT TRIAL: study protocol for a randomized controlled trial on endoscopic ultrasound-guided biliary drainage of first intent with a lumen-apposing metal stent vs. endoscopic retrograde cholangio-pancreatography in the management of malignant distal biliary obstruction. Trials. 2019 Dec 9;20(1):696. doi: 10.1186/s13063-019-3918-y.
PMID: 31818329BACKGROUNDGarcia-Sumalla A, Loras C, Sanchiz V, Sanz RP, Vazquez-Sequeiros E, Aparicio JR, de la Serna-Higuera C, Luna-Rodriguez D, Andujar X, Capilla M, Barbera T, Foruny-Olcina JR, Martinez B, Dura M, Salord S, Laquente B, Tebe C, Videla S, Perez-Miranda M, Gornals JB; Spanish Working Group on Endoscopic Ultrasound Guided Biliary Drainage. Multicenter study of lumen-apposing metal stents with or without pigtail in endoscopic ultrasound-guided biliary drainage for malignant obstruction-BAMPI TRIAL: an open-label, randomized controlled trial protocol. Trials. 2022 Feb 25;23(1):181. doi: 10.1186/s13063-022-06106-1.
PMID: 35216619BACKGROUNDTeoh AYB, Napoleon B, Kunda R, Arcidiacono PG, Kongkam P, Larghi A, Van der Merwe S, Jacques J, Legros R, Thawee RE, Saxena P, Aerts M, Archibugi L, Chan SM, Fumex F, Kaffes AJ, Ma MTW, Messaoudi N, Rizzatti G, Ng KKC, Ng EKW, Chiu PWY. EUS-Guided Choledocho-duodenostomy Using Lumen Apposing Stent Versus ERCP With Covered Metallic Stents in Patients With Unresectable Malignant Distal Biliary Obstruction: A Multicenter Randomized Controlled Trial (DRA-MBO Trial). Gastroenterology. 2023 Aug;165(2):473-482.e2. doi: 10.1053/j.gastro.2023.04.016. Epub 2023 Apr 28.
PMID: 37121331RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Joan B Gornals Soler
Study Principal Investigator
- PRINCIPAL INVESTIGATOR
Carme Loras
Hospital Universitari Mutua de Terrassa
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD and Head of Interventional Endoscopy Unit
Study Record Dates
First Submitted
April 16, 2024
First Posted
April 19, 2024
Study Start
October 18, 2024
Primary Completion (Estimated)
October 1, 2026
Study Completion (Estimated)
October 1, 2027
Last Updated
May 6, 2026
Record last verified: 2026-05